Impex Pharmacare Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 9 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
About Impex Pharmacare
Impex Pharmacare Private Limited (IPPL) is a Private Limited Indian Non-Government Company incorporated in India on 25 November 2015 (Nine years and three months 0 days old ). Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Archana Pandey, Samriddhi Pandey, and Rithika Pandey serve as directors at the Company.
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U74900MH2015PTC270465
- Company No.
270465
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
25 Nov 2015
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
What products or services does Impex Pharmacare Private Limited offer?
Impex Pharmacare Private Limited offers a wide range of products and services, including Antibiotic Injection, Meropenem Injection.
Who are the key members and board of directors at Impex Pharmacare?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Samriddhi Pandey  | Director | 20-Apr-2016 | Current |
| Rithika Pandey | Director | 10-Sep-2019 | Current |
| Archana Pandey | Director | 25-Nov-2015 | Current |
Financial Performance of Impex Pharmacare.
Impex Pharmacare Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Impex Pharmacare?
In 2017, Impex Pharmacare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Defy Aerospace Private LimitedArchana Pandey and Samriddhi Pandey are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Impex Pharmacare?
Unlock and access historical data on people associated with Impex Pharmacare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Impex Pharmacare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Impex Pharmacare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
